Yibin Kang
Personal Data
Address: Department
of Molecular Biology
Princeton University
LTL
255, Washington Road
Princeton, NJ
08544
Phone: (609) 258-8834
Fax: (609) 258-2340
E-mail: ykang@molbio.princeton.edu
URL: http://www.molbio1.princeton.edu/kang/
Education
• 1991-1995 B.S. (Genetics) Fudan University, Shanghai,
China
• 1996-2000 Ph.D.
(Genetics) Duke
University, Durham, NC
Honors and Awards
• 1990 First
prize, National High School Chemistry Competition, China
• 1991-1995 Fudan
University People’s Scholarship
• 1993 Fudan University
Mao Cheng-Si Scholarship
• 1994 Fudan University
Xu Zeng-Shou Scholarship
• 1995 Fudan University
Outstanding Graduate Award
• 2001-2004 Irvington
Institute Postdoctoral Fellowship for Immunological Research
• 2004 AIMM-ASBMR
John Haddad Young Investigator Award
• 2004 Memorial Sloan-Kettering Cancer
Center Annual
Postdoctoral Research Award
• 2005 The Padget
Foundation Young Investigator Award
• 2005 American
Cancer Society Research Scholar Award
• 2006 Department
of Defense Breast Cancer Research Program Era of Hope Scholar Award
Professional Experience
• 1993-1995 Undergraduate Research Assistant at Dr.
Jianhua Chai’s Laboratory
Department of Genetics, Fudan University,
Shanghai, China
Physical and expression
mapping of the subcentromeric regions (Xp11.2 and Xp21.1-21.3) in the short arm
of the human X chromosome.
• 1996-2000 Graduate
Research Assistant at Dr. Bryan R. Cullen’s Laboratory
Department of Genetics and Howard
Hughes Medical Institute
Duke
University Medical
Center, Durham, NC
Transcriptional and
post-transcriptional regulation of eukaryotic gene expression, using retroviruses
as a model system.
• 2000-2004 Postdoctoral Research Associate at Dr. Joan
Massagué’s Laboratory
Cell Biology Program and Howard Hughes
Medical Institute
Memorial
Sloan-Kettering Cancer Center, New York
TGFb cytostasis
program and the role of TGFb in
tumorigenesis and metastasis of human cancer.
Molecular basis of breast cancer bone metastasis.
• 2004-present Assistant Professor
Department of Molecular Biology, Princeton University,
Princeton, NJ
Associate Member, Cancer Institute of New Jersey, New
Brunswick, NJ
Using functional genomics and systems biology approaches to
study molecular mechanisms of cancer metastasis. Signaling pathways involved in tumor-stroma
interactions during metastasis.
Professional Membership
• American
Association for Cancer Research (AACR)
• American
Association for Advancement of Science (AAAS)
• American Society of
Biochemistry & Molecular Biology (ASBMB)
• Chinese Biological
Investigator Society (CBIS)
• Metastasis Research
Society (MRS)
Invited
Lectures
·
AIMM-ASBMR John Haddad Young Investigators
Meeting, Snowmass, Colorado
(3/30/2004)
·
Hermelin
Brain Tumor
Center Symposium on Metastatic
Disease, Henry Ford
Hospital, Detroit, Michigan
(5/7/2004)
- 34th International Sun Valley
Workshop on Skeletal Tissue Biology, Sun
Valley, Idaho
(8/1/2004)
- 10th International Congress
of Metastasis Research Society, Genoa,
Italy
(9/17/2004)
- Fred
Hutchinson Cancer
Center, Seattle, Washington
(11/23/2004)
- Biomolecular Technologies:
Discovery to Hypothesis, Savannah,
Georgia
(02/06/2005)
- Alfred
I. Dupont
Hospital, Wilmington, Delaware
(03/21/2005)
- Skeletal Complications of
Malignancy IV, Bethesda,
Maryland (04/30/2005)
- EuroCancer 2005, Paris, France
(06/22/2005)
- The Cancer Institute of New Jersey, New
Brunswick, New Jersey
(10/18/2005)
- AACR Special Conference:
Cancer, Protease and Tumor Microenvironmen, Bonita
Springs, Florida (12/2/2005)
- Society of Chinese Biological
Investigators Annual Meeting, Boulder,
Colorado (12/19/2005)
- Annual Retreat on Cancer
Research in New Jersey, Piscataway, New Jersey
(5/25/2006)
- BRECOSM Breast Cancer and
Metastasis Meeting, Paris,
France
(6/22/2006)
- 11th International
Congress of Metastasis Research Society, Tokushima, Japan
(9/3/2006)
- National
Cancer Center,
Tokyo, Japan (9/7/2006)
- University of Massachusetts
Medical Center,
Worcester, Massachusetts (10/25/2006)
- Duke
University, Durham, North Carolina
(11/09/2006)
- VI International Meeting on
Cancer Induced Bone Disease, San
Antonio, Texas
(12/10/2006)
- Rutgers University,
(2/5/2006)
- The 2nd New York Academy
of Sciences
Conferences on Skeletal Biology and Medicine (4/27/2007)
- Gordon Research Conference, Biddeford, Maine
(7/15/2007)
- Skeletal Complications of
Malignancy V, Philadelphia,
Pennsylvania (10/25/2007)
Peer-reviewed
Publications
1. Kang Y, Blair WS, and Cullen BR. (1998) Identification and
functional characterization of a high affinity Bel-1 DNA binding site located
in the human foamy virus internal promoter.
J. Virol., 72:504-11.
2. Kang Y, and Cullen BR.
(1998) Derivation and functional characterization of the consensus DNA binding
sequence for the Tas transcriptional activator of simian foamy virus type 1. J.
Virol., 72:5502-9.
3. Kang Y, and Cullen BR.
(1999) The human Tap protein is a nuclear mRNA export factor that contains
novel RNA binding and nucleocytoplasmic transport sequences. Genes
& Dev., 13:1126-39.
Editorial by: Strambio-de-Castillia
C, and Rout MP. (1999) Nature Cell Biol.,
1: E31-2.
4. Kang Y, Bogerd H, Yang J, and Cullen BR. (1999) Analysis of the RNA
binding specificity of the human Tap nuclear RNA export factor. Virology, 262:200-9.
5. Truant R*, Kang
Y*, and Cullen BR.
(1999) The human Tap nuclear RNA export factor contains a novel transportin
dependent NLS that lacks NES function. J. Biol. Chem., 274:32167-71.
* The
first two authors contributed equally to this work.
6. Kang Y, Bogerd H, and Cullen BR. (2000) Analysis of cellular
factors that mediate nuclear export of RNAs bearing the Mason-pfizer monkey
virus constitutive transport element. J. Virol., 74:5863-71.
7. Neufeld KL, Nix DA, Bogerd
H, Kang Y, Beckerle MC, Cullen BR,
and White RL. (2000) Nuclear export of Adenmatous Polyposis Coli protein
regulate b-Catenin levels in the nucleus. Proc. Natl. Acad. Sci., 97:12085-90.
8. Chen C*, Kang Y*, and Massagué
J. (2001) Defective repression of c-myc
in breast cancer cells: A loss at the core of the TGF-b growth arrest program. Proc. Natl. Acad. Sci., 98:992-9.
* The first two
authors contributed equally to this work.
9. Coburn GA, Wiegand HL, Kang Y, Ho DN, Georgiadis MM, and
Cullen BR. (2001) Using viral species specificity to define a protein: RNA
interaction surface. Genes & Dev., 15:1194-205.
10. Wiegand HL, Coburn GA, Zeng Y, Kang Y, Bogerd HP, and Cullen BR.
(2002) Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA
export by enhancing recruitment to nuclear pore complex. Mol. Cell Biol., 22:245-56.
11. Ho DN, Coburn GA, Kang Y,
Cullen BR, and Georgiadis MM. (2002) The crystal structure and mutational
analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA
export factor. Proc. Natl. Acad. Sci., 99:1888-93.
12. Chen C, Kang Y, Siegel PM, and Massagué J. (2002) E2F4/5 and p107 as Smad
cofactors linking the TGFb receptor to c-myc repression. Cell, 110:19-32.
Editorial
by: Kowalik TF. (2002) Mol. Cell, 10:7-8.
13. Xu L, Kang Y, Col S, and Massagué J. (2002) Smad2 nucleocytoplasmic
shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFb signaling complexes in the cytoplasm and nucleus. Mol. Cell, 10:271-82.
Editorial by: Heinrichs A. (2002) Nature
Reviews Mol. Cell Biol., 3:728.
14. Kang Y, Chen C, and
Massagué J. (2003) A self-enabling TGFb response
coupled to stress signaling: Smad engages stress response factor ATF3 for Id1
repression in epithelial cells. Mol. Cell, 11:915-26.
15. Kang Y, Siegel PM, Shu WP,
Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, and Massagué J. (2003) A
multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3:537-49. (Cover Article)
Editorial by: Hynes RO. (2003) Cell,
113:821-23.
Pilcher HR. (2003) Nature, 424:143.
van’t Veer LJ,
and Weigelt B. (2003) Nature Medicine,
9:999-1000.
Greenwood E. (2003) Nature Reviews Cancer, 3:549.
Welch DR. (2004) Breast Cancer Research, 6:61-4.
16. Bodem J, Kang Y and Flügel RM. (2004) Comparative functional
characterization of the feline foamy virus transactivator reveals its species
specificity. Virology, 318:32-6.
17. Kang Y and Massagué J. (2004) Epithelial-mesenchymal transition:
twist in development and metastasis. Cell, 118:277-9.
18. Minn AJ, Kang Y, Gupta G, Panomarev V, Serganova I, Blasberg R, and
Massagué J. (2005) Distinct organ-specific metastasis potential of individual
breast cancer cells carrying a uniform poor-prognosis gene expression signature. J. Clin. Invest., 115:44-55.
Editorial by: Hutchinson E. (2005) Nature Reviews Cancer, 5:88.
19. Kang Y (2005) Functional genomics analysis of cancer metastasis:
biologic insights and clinical implications. Expert Rev.
Mol. Diagn., 5: 385-95.
20. Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen C,
Manova-Todorava K, Blasberg R, Gerald WL, and Massagué J. (2005) Breast
cancer bone metastasis mediated by Smad tumor suppressor pathway. Proc. Natl. Acad. Sci., 102:
13909-14.
21. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I,
Cordon-Cardo C, Olshen AB, Gerald WL, and Massagué J. (2005) Identifying site-specific
metastasis genes and functions. Cold Spring Harb Symp Quant
Biol. 70: 1-10.
22. Kang Y. (2006) Pro-metastatic function of TGFb mediated by the Smad pathway. J. Cell. Biochem., 98:
1380-90.
23. Kang Y. (2006) New tricks against an old foe: dissecting tissue
tropism in breast cancer metastasis. Breast Disease, in press.
24. Li F, Tiede B, Massagué
J and Kang Y. (2006) Beyond tumorigenesis:
the role of cancer stem cells in metastasis. Submitted.